Related Experiment Video
Updated: Dec 5, 2025
07:53
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
11.4K
Lipid Drug Carriers for Cancer Therapeutics: An Insight into Lymphatic Targeting, P-gp, CYP3A4 Modulation and
Shashank Chaturvedi1, Anurag Verma2, Vikas Anand Saharan3
1Department of Pharmaceutics, Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India.
Advanced Pharmaceutical Bulletin
|October 19, 2020
Summary
Lipid-based drug carriers enhance oral anti-cancer drug efficacy by improving solubility and overcoming multidrug resistance (MDR). These systems target the lymphatic system, maximizing therapeutic safety and effectiveness.
Area of Science:
- Pharmacology
- Drug Delivery
- Nanotechnology
Background:
- Oral anti-cancer drug efficacy is limited by poor solubility, membrane permeability, P-glycoprotein (P-gp) efflux, and pre-systemic metabolism, leading to multidrug resistance (MDR).
- Lipid-based carrier systems offer a promising strategy to address these challenges in chemotherapy.
Purpose of the Study:
- To review the utility of various lipid-based drug delivery systems (liposomes, solid lipid nanoparticles, nano-lipid carriers, self-emulsifying systems, lipidic prodrugs) for enhancing anti-cancer drug delivery.
- To highlight the role of these systems in targeting the lymphatic system and overcoming drug resistance mechanisms.
- To discuss the potential of lipid carriers in improving the safety and efficacy of anti-cancer therapies.
Main Methods:
- Review of existing literature on lipid-based drug delivery systems for anti-cancer agents.
- Analysis of mechanisms by which lipid carriers improve drug solubility, permeability, and circumvent efflux pumps (P-gp, CYP3A4).
- Evaluation of lymphatic targeting strategies using lipid formulations, particularly long-chain triglycerides (LCTs).
Main Results:
- Lipid-based formulations demonstrate significant potential in enhancing the solubility and permeability of poorly soluble anti-cancer drugs.
- These systems can effectively bypass P-gp mediated efflux and pre-systemic metabolism, thereby increasing drug bioavailability.
- Long-chain triglycerides (LCTs) facilitate lymphatic uptake, enabling targeted delivery of anti-cancer drugs to proliferating cells.
Conclusions:
- Lipid-based drug carriers are crucial for overcoming major obstacles in oral anti-cancer chemotherapy, including poor solubility and multidrug resistance.
- Targeting the lymphatic system with lipid formulations represents a viable strategy for improving anti-cancer drug delivery and therapeutic outcomes.
- The strategic use of lipid-based systems holds significant promise for maximizing both the safety and efficacy of cancer treatment.
Related Concept Videos
01:27Bioavailability Enhancement: Drug Permeability Enhancement
104
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
104
01:06Carrier-Mediated Transport
826
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
826
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
110
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
110
02:57Targeted Cancer Therapies
8.3K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.3K
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
78
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
78
01:16Bioavailability Enhancement: Drug Solubility Enhancement
122
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
122